Back

COP9 Signalosome Promotes Neointimal Hyperplasia via Deneddylation and CSN5-Mediated Nuclear Export

Giri, S.; Suo, C.; Pardi, R.; Fishbein, G. A.; Rezvani, K.; Chen, Y.; Wang, X.

2023-04-12 cell biology
10.1101/2023.04.11.536468 bioRxiv
Show abstract

BACKGROUNDNeointimal hyperplasia (NH) is a common pathological response to vascular injury and mediated primarily by vascular smooth muscle cell (VSMC) migration and proliferation. The COP9 signalosome (CSN) is formed by 8 canonical subunits (CSN1 through CSN8) with its deneddylation activity residing in CSN5. Each or some of CSN subunits may have deneddylation-independent function. Despite strong evidence linking the CSN to cell cycle regulation in cancer cells, the role of the CSN in vascular biology remains obscure. METHODSNeointimal CSN5 expression in the lung tissue of pulmonary hypertension (PAH) patients was assessed with immunohistochemistry. Adult mice with smooth muscle cell-restricted CSN5 knockout (CSN5-SMKO) or CSN8 hypomorphism (CSN8-hypo) and cultured mouse VSMCs were studied to determine the role and governing mechanisms of the CSN in NH. NH was induced by ligation of the left common carotid artery (LCCA) and PDGF-BB stimulation was used to mimic the vascular injury in cell cultures. RESULTSRemarkably higher CSN5 levels were detected in the neointimal VSMCs of the pulmonary arteries of human PAH. LCCA ligation induced NH and significantly increased the mRNA and protein levels of CSN subunits in the LCCA wall of adult wild type mice. CSN5-SMKO impaired Cullin deneddylation and the nuclear export of p27 in vessel walls and markedly inhibited VSMC proliferation in mice. On the contrary, CSN8-hypo significantly exacerbated NH and VSMC proliferation in vivo and in cellulo. Cytoplasmic CSN5 mini-complexes and the nuclear export of p27 were significantly increased in CSN8-hypo mouse vessels and cultured CSN8-hypo VSMCs. Nuclear export inhibition with leptomycin attenuated the PDGF-BB-induced increases in VSMC proliferation in both CSN8-hypo and control VSMCs. Further, genetically disabling CSN5 nuclear export but not disabling CSN5 deneddylase activity suppressed the hyperproliferation and restored p27 nuclear localization in CSN8 hypomorphic VSMCs. Interestingly, CSN deneddylase inhibition by CSN5i-3 did not alter the hyperproliferation of cultured CSN8-hypo VSMCs but suppressed wild type VSMC proliferation in cellulo and in vivo and blocked neointimal formation in wild type mice. CONCLUSIONThe CSN promotes VSMC proliferation and NH in injured vessels through deneddylation activity and CSN5-mediated nuclear export.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.1%
41.6%
2
Hypertension
32 papers in training set
Top 0.1%
6.6%
3
Cardiovascular Research
33 papers in training set
Top 0.1%
5.1%
50% of probability mass above
4
PLOS ONE
4510 papers in training set
Top 35%
4.2%
5
Journal of the American Heart Association
119 papers in training set
Top 2%
3.8%
6
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 0.9%
3.8%
7
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.1%
3.2%
8
Circulation Research
39 papers in training set
Top 0.6%
1.9%
9
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.5%
1.7%
10
JCI Insight
241 papers in training set
Top 3%
1.7%
11
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.5%
1.6%
12
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.6%
13
JACC: Basic to Translational Science
15 papers in training set
Top 0.3%
1.2%
14
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.0%
15
European Heart Journal
16 papers in training set
Top 0.6%
0.9%
16
Scientific Reports
3102 papers in training set
Top 70%
0.9%
17
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.8%
0.8%
18
Annals of Translational Medicine
17 papers in training set
Top 1%
0.8%
19
Physiological Reports
35 papers in training set
Top 1%
0.8%
20
Angiogenesis
15 papers in training set
Top 0.2%
0.8%
21
Arthritis & Rheumatology
33 papers in training set
Top 0.5%
0.7%
22
eLife
5422 papers in training set
Top 60%
0.7%
23
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 46%
0.7%
24
Journal of Applied Physiology
29 papers in training set
Top 0.6%
0.5%